Join
Live feed
·
INSIDERFilingvia Quantisnow
TScan Therapeutics Inc. logo

Large owner Lynx1 Capital Management Lp bought $1,666,553 worth of shares (1,388,794 units at $1.20) and bought $1,440,000 worth of shares (1,200,000 units at $1.20) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRX (TScan Therapeutics Inc.) and more on Quantisnow.